Tag: IPF

Trevi Therapeutics hits 50% enrollment in IPF cough research By Investing.com

NEW HAVEN, Conn. - Trevi Therapeutics, Inc. (NASDAQ:), a clinical-stage biopharmaceutical firm,…

By admin